CJC-1295 with DAC (5mg)
CJC-1295 with DAC — 5mg | Research Grade | Australia
CJC-1295 with DAC is a synthetic analogue of growth hormone releasing hormone (GHRH), structurally modified with a Drug Affinity Complex (DAC) to extend circulatory half-life via albumin binding in preclinical research models. This mechanism has made it one of the more widely examined long-acting GHRH analogues in the peer-reviewed literature. Buy CJC-1295 DAC in Australia from Austides — research-grade, third-party tested, domestically dispatched.
Research Applications
Studied in preclinical models for its effects on sustained GH and IGF-1 signalling via albumin-mediated half-life extension
Examined in animal research for its influence on muscle protein synthesis pathway markers
Investigated in preclinical settings for its effects on adipose tissue metabolism in the context of GH signalling
Subject of preclinical research into sleep architecture parameters and cellular repair mechanisms in animal models
Frequently used in combination preclinical research protocols alongside GHRPs such as Ipamorelin
Product Specifications
Classification | GHRH Analogue (Long-Acting) |
Molecular Weight | 3647.3 g/mol |
Half-Life | 6–8 days (with DAC, in research models) |
Form | Lyophilised powder |
Purity | ≥99% (HPLC verified) |
Storage | Store at -20°C, away from light. Stable 24 months unopened. |
Austides Standard
All Austides peptides are third-party tested for purity and potency. Domestically dispatched from Australia with discrete, secure packaging and cold-chain integrity maintained throughout.
For research purposes only. Not for human consumption, therapeutic use, or self-administration. This product is not approved by the TGA for any therapeutic application.
){kind=link}